Tracking family health history has long been recognized as a vital component of preventive healthcare. When conditions such as diabetes, heart disease, or colon cancer are prevalent across generations of a family tree, individuals are routinely advised that they may face an elevated risk of developing those same medical issues. However, among men, one critical chapter of the family medical narrative is frequently overlooked or dismissed entirely: a history of breast cancer.
Because breast cancer is overwhelmingly associated with women, many men assume that genetic markers associated with the disease have no relevance to their own personal health. Even when a male relative learns that breast cancer or pathogenic genetic variants run in the family—such as mutations in the well-known BRCA1 or BRCA2 genes—the widespread assumption is often that men are inherently out of harm’s way. Medical experts emphasize that this assumption is fundamentally incorrect.
"Men think of BRCA1 and BRCA2 and they think of typically female diseases, so they assume it doesn’t matter to them," explains Jane Lowe Meisel, MD, a medical oncologist at the Emory Winship Cancer Institute in Atlanta and an American Society of Clinical Oncology expert in breast cancer. "But men can have those genes too."
Far from being exclusive to female biology, the identical gene changes that dramatically heighten a woman’s susceptibility to breast and ovarian malignancies also carry significant clinical implications for men. Specifically, carrying a BRCA mutation elevates a man’s risk of developing prostate cancer and male breast cancer. Furthermore, these genetic alterations increase the risk of pancreatic cancer in both men and women. Consequently, oncologists stress that understanding one’s complete family health history is an essential tool for early detection and proactive healthcare management.
What to look for in your family
Encountering a diagnosis of breast cancer within a broader family tree is relatively common. According to established health statistics, approximately one out of every eight women in the United States will develop breast cancer at some point during her lifetime. Because the disease is so widespread among women, an isolated diagnosis in a female relative does not automatically signal a hereditary cancer syndrome that will impact male family members.
"Breast cancer in women is so common, and the vast majority of men related to those women won’t have to deal with breast cancer," notes Dr. Meisel.
The clinical picture changes, however, when a family exhibits what medical professionals define as a strong family history of the disease. In these instances, patterns of cancer incidence across relatives can point toward an underlying genetic predisposition.
According to Giacomo Montagna, MD, MPH, a breast surgeon and co-director of the Rare Breast Cancer Program at Memorial Sloan Kettering Cancer Center, assessing family history requires evaluating specific red flags and clinical patterns. A strong family history is often characterized by multiple cases of breast cancer on the same side of the family, diagnoses occurring at unusually young ages, instances of male breast cancer among relatives, or overlapping occurrences of associated malignancies such as ovarian, prostate, or pancreatic cancers across multiple generations. Recognizing these patterns serves as the critical first step in determining whether further medical evaluation is warranted.
Dive deep into what’s going on
When a strong family history of cancer is identified, patients and their physicians face a pivotal diagnostic question: could an inherited genetic mutation be driving the cluster of cancers observed within the family?
While BRCA1 and BRCA2 are the most widely recognized genes linked to inherited risk, researchers have discovered more than 20 additional genes that influence breast cancer susceptibility. Determining whether a person carries a variant in one of these critical genes can be accomplished through simple, accessible laboratory testing. Modern genetic evaluation typically requires only a basic blood test, and many of the newest diagnostic platforms can analyze inherited risk using just a saliva sample.
"If your test is positive, you were born with a genetic predisposition to develop cancer," says Dr. Montagna.
For individuals who already have a relative—whether male or female—who has tested positive for a BRCA mutation, genetic testing remains essential. Inheriting a genetic mutation is not a certainty; rather, it follows standard inheritance patterns. The statistical probability that a parent carrying a BRCA mutation will pass the genetic alteration on to their child is precisely 50 percent. Similarly, an individual faces a 50-50 chance of carrying the mutation if one of their biological siblings or children tests positive.
Oncologists emphasize that these biological odds remain identical regardless of biological sex. "There’s a misconception that the BRCA gene only affects women, but it’s not true at all," Dr. Montagna explains. "Males have the exact same risk of acquiring the mutation from their parents."
To fully appreciate how these mutations impact health, it is helpful to understand the baseline function of BRCA genes within the human body. Every individual is born with both BRCA1 and BRCA2 genes. In their normal state, these genes play a vital protective role in cellular biology by functioning as internal machinery designed to repair errors in cellular code.
"They are DNA repair mechanisms," Dr. Montagna clarifies.
Throughout a person’s life, normal metabolic processes and environmental exposures inevitably cause routine mistakes and damages in cellular DNA. Standard BRCA genes continuously repair these errors, preserving genetic integrity and preventing abnormal cell growth. However, when a person inherits a pathogenic mutation in a BRCA gene, that crucial DNA repair work is disrupted and cannot function as intended. Without operational repair mechanisms, genetic mistakes accumulate within cells over time. As Dr. Montagna notes, "At the end of the day, a cancer cell is one with a lot of DNA mistakes."
Although BRCA1 and BRCA2 are often discussed together, they are distinct genes, and mutations in each gene influence male cancer risk differently—particularly regarding male breast cancer.
Within the general male population, breast cancer is an exceptionally rare disease. Among men who do not carry a genetic predisposition, the baseline lifetime risk of developing breast cancer is roughly 1 in 1,000. However, carrying a pathogenic genetic mutation alters those odds dramatically.
"If you have the BRCA1 mutation, the risk is about 1/100, or 1%," explains Dr. Montagna. "And if you carry the BRCA2 change, the risk goes up to 7%. It really significantly increases."
You have a BRCA mutation—now what?
Receiving a positive result for a BRCA mutation can be overwhelming, but medical experts emphasize that a positive genetic test is not a cancer diagnosis. Carrying a mutation simply indicates an increased statistical risk, providing actionable insight that allows men and their healthcare providers to implement targeted monitoring strategies.
"First, take a deep breath," medical experts advise. A positive test does not guarantee that a man will ultimately develop male breast cancer or any other associated malignancy. It does, however, signal a need for heightened physical awareness and proactive healthcare management.
A primary challenge in treating male breast cancer is that men are rarely included in routine cancer screening programs, such as regular mammography. As a result, men are far less likely to catch early warning signs, often delaying medical consultation until the disease has progressed.
"Men aren’t screened for breast cancer, so they tend to present with more advanced cancer," explains Dr. Montagna. "They’ll say they had a lump for years by the time they see a breast cancer specialist, so the tumors are more advanced."
To prevent delays in diagnosis, men—especially those with known genetic risks—must understand what signs to monitor. "The most common symptom is a painless mass behind your nipple," Dr. Montagna says. "Most breast cancer in men is behind the nipple because that’s where the milk-duct structures are."
Beyond a painless subareolar lump, other key physical symptoms of male breast cancer can include localized nipple discharge or nipple retraction, where the nipple begins to turn inward. Because routine imaging is not standard for men, self-awareness is the primary line of defense.
"Prevention is mostly monthly self-awareness exams," says Dr. Meisel. "Know what your chest feels like so you can bring up changes to your doctor."
Because BRCA mutations also increase the likelihood of developing prostate and pancreatic cancers, men who test positive should engage in detailed discussions with their primary care physicians and specialists regarding tailored screening regimens for those conditions as well. Developing a comprehensive health plan ensures that potential abnormalities in any susceptible organ system can be investigated promptly.
"All men should be aware of their body," Dr. Meisel emphasizes. "Something odd might be nothing, but if it is something, you’ll be glad you caught it early."
For men navigating the complexities of genetic risk, guidance is available beyond their primary care physician or oncologist. Individuals who have questions regarding their test results or what a positive mutation means for their broader family are encouraged to consult with a certified genetic counselor. These specialized healthcare professionals can interpret complex genetic reports, clarify the specific health implications, assist in communicating risk factors to biological relatives, and offer guidance on family planning and the potential transmission of inherited mutations to future children.
